Neuronetics Inc. (STIM)

Name: Neuronetics Inc. (STIM) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Neuronetics Inc. (STIM)

Stock Card

$3.00

$0.02 (0.67%)

As on 26-Aug-2026 16:00EDT

Market cap

$229 Mln

Revenue (TTM)

$155 Mln

P/E Ratio

P/B Ratio

12.8

Div. Yield

0 %

Neuronetics (STIM) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.88 High: 3.02

52 Week Range

Low: 0.80 High: 3.71

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.2 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-2
Debt to Equity

0
Book Value

$--
EPS

$-0.4
Face value

--
Shares outstanding

76,197,222

8 Years Aggregate

CFO

$-189.91 Mln

EBITDA

$-172.19 Mln

Net Profit

$-222.97 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Neuronetics (STIM)	117.4	73.4	150.0	-6.3	23.1	-16.8	--
BSE Sensex^*	-8.7	1.6	1.7	-4.3	6.0	6.7	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Aug-2026 | *As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Neuronetics (STIM)	-14.3	-44.2	-57.8	54.0	-59.9	147.4	-76.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Neuronetics (STIM)	3.0	228.6	155.1	-30.4	-14.8	-149.3	--	12.8
10X Genomics Inc (TXG)	64.3	8,484.6	616.9	-75.1	1.7	-9.3	--	10.1
Avantor (AVTR)	14.5	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	9,074.5	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	180.6	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,525.3	1,556.3	275.3	24.6	22.9	24	5.0
Merit Medical Systems (MMSI)	90.5	5,420.5	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	323.1	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	180.3	10,222.2	785.1	41.5	9.9	2	251.6	4.8

Shareholding Pattern

View Details

About Neuronetics (STIM)

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based... treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Read more

President, CEO & Director

Mr. Keith J. Sullivan
President, CEO & Director

Mr. Keith J. Sullivan
Headquarters

Malvern, PA
Website

https://neurostar.com/neuronetics

FAQs for Neuronetics (STIM)

What is the current share price of Neuronetics Inc (STIM) Today?

The share price of Neuronetics Inc (STIM) is $3.00 (NASDAQ) as of 26-Aug-2026 16:00 EDT. Neuronetics Inc (STIM) has given a return of 23.05% in the last 3 years.

What is the current PB & PE ratio of Neuronetics Inc (STIM)?

Since, TTM earnings of Neuronetics Inc (STIM) is negative, P/E ratio is not available.
The P/B ratio of Neuronetics Inc (STIM) is 12.81 times as on 21-Aug-2026, a 234 premium to its peers’ median range of 3.84 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-2.43	4.24
2024	-1.35	2.13
2023	-2.79	2.46
2022	-5.03	3.28
2021	-3.77	1.38

What is the 52 Week High and Low of Neuronetics Inc (STIM)?

The 52-week high and low of Neuronetics Inc (STIM) are Rs 3.71 and Rs 0.80 as of 27-Aug-2026.

What is the market cap of Neuronetics Inc (STIM)?

Neuronetics Inc (STIM) has a market capitalisation of $ 229 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Neuronetics Inc (STIM)?

Before investing in Neuronetics Inc (STIM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.